Related references
Note: Only part of the references are listed.2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results
Khalid Al-Rasadi et al.
CURRENT VASCULAR PHARMACOLOGY (2020)
Xanthomas Can Be Misdiagnosed and Mistreated in Homozygous Familial Hypercholesterolemia Patients: A Call for Increased Awareness Among Dermatologists and Health Care Practitioners
Fahad Alnouri et al.
GLOBAL HEART (2020)
Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease A Systematic Review and Meta-Analysis
Pengwei Hu et al.
CIRCULATION (2020)
Worldwide Prevalence of Familial Hypercholesterolemia Meta-Analyses of 11 Million Subjects
Sabina O. Beheshti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Anxiety, depression, and health-related quality of life in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis
Leo E. Akioyamen et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2018)
Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia
Fahad Alnouri et al.
ATHEROSCLEROSIS (2018)
Spectrum of mutations of familial hypercholesterolemia in the 22 Arab countries
Dalal Alhababi et al.
ATHEROSCLEROSIS (2018)
Familial Hypercholesterolaemia Diagnosis and Management
Rodrigo Alonso et al.
EUROPEAN CARDIOLOGY REVIEW (2018)
Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied
Leo Ungar et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Assessment of physicians' awareness and knowledge of familial hypercholesterolemia in Saudi Arabia: Is there a gap?
Mohammed Ali Batais et al.
PLOS ONE (2017)
Familial Hypercholesterolemia: a Systematic Review of Guidelines on Genetic testing and Patient management
Giuseppe Migliara et al.
FRONTIERS IN PUBLIC HEALTH (2017)
Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death
Henriette Walaas Krogh et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Alberico L. Catapano et al.
ATHEROSCLEROSIS (2016)
Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States Data From the CASCADE-FH Registry
Emil M. deGoma et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
Dhruv S. Kazi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States Data From the CASCADE-FH Registry
Emil M. deGoma et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Familial hypercholesterolaemia: A global call to arms
Antonio J. Vallejo-Vaz et al.
ATHEROSCLEROSIS (2015)
Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus
Joost Besseling et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2015)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2015)
HOMOZYGOUS AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA IN THE NETHERLANDS: PREVALENCE, GENOTYPE-PHENOTYPE RELATIONSHIP AND CLINICAL OUTCOME
Barbara Sjouke et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort
Matthew D. Allard et al.
LIPIDS IN HEALTH AND DISEASE (2014)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
EUROPEAN HEART JOURNAL (2014)
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2013)
Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication
Marianne Benn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy
Frederick J. Raal et al.
CIRCULATION (2011)
Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: A large cross-sectional study in The Netherlands
A. H. Pijlman et al.
ATHEROSCLEROSIS (2010)
Consanguinity among the Kuwaiti population
S. A. Al-Awadi et al.
CLINICAL GENETICS (2010)
Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
Ian Hamilton-Craig et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2010)
National Institutes of Health State-of-the-Science Conference Statement: Family History and Improving Health
Alfred O. Berg et al.
ANNALS OF INTERNAL MEDICINE (2009)
Smoking in Saudi Arabia and its relation to coronary artery disease
Mansour M. Al-Nozha et al.
JOURNAL OF THE SAUDI HEART ASSOCIATION (2009)
Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
Andrew Neil et al.
EUROPEAN HEART JOURNAL (2008)
Efficacy of statins in familial hypercholesterolaemia: a long term cohort study
Jorie Versmissen et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia
F Civeira
ATHEROSCLEROSIS (2004)
Genetic causes of monogenic heterozygous familial hypercholesterolemia: A HuGE prevalence review
MA Austin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
HAW Neil et al.
HEART (2004)
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
DJ Rader et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
CA Jackevicius et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
